<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2071-8713-4834</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-4834</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Современные аспекты лечения метаболическогосиндрома</article-title><trans-title-group xml:lang="en"><trans-title>Sovremennye aspekty lecheniya metabolicheskogosindroma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Plokhaya</surname><given-names>A A</given-names></name></name-alternatives><email xlink:type="simple">Plohay.Anna@endocrincentr.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>15</day><month>09</month><year>2011</year></pub-date><volume>8</volume><issue>3</issue><issue-title>№3 (2011)</issue-title><fpage>31</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Plokhaya A.A., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Plokhaya A.A.</copyright-holder><copyright-holder xml:lang="en">Plokhaya A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/4834">https://www.omet-endojournals.ru/jour/article/view/4834</self-uri><abstract><p>Известно, что метаболический синдром предшествует возникновению сердечно-сосудистой патологии, сахарного диабета 2 типа и повышает риск ассоциированной с ними смертности. Однако это состояние является обратимым,
так как при правильном лечении можно добиться исчезновения или, по крайней мере, уменьшения выраженности основных
его проявлений. В статье отражены современные подходы к терапии метаболического синдрома.</p></abstract><trans-abstract xml:lang="en"><p>It is known that the metabolic syndrome precedes the occurrence of cardiovascular pathology and type 2 diabetes, and increases
the risk for the associated death. However, this condition is reversible, and may be cured, or the reduction of its main symptoms could
be observed. The article demonstrates the current approach to the therapy of the metabolic syndrome.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>метаболический синдром</kwd><kwd>инсулинорезистентность</kwd><kwd>адипоцитокины</kwd><kwd>критерии диагностики</kwd><kwd>орлистат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metabolic syndrome</kwd><kwd>insulin resistance</kwd><kwd>adipocytokines</kwd><kwd>diagnostic criteria</kwd><kwd>orlistat</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению // РМЖ. - 2001. - № 9 (2). - С. 56-60.</mixed-citation><mixed-citation xml:lang="en">Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению // РМЖ. - 2001. - № 9 (2). - С. 56-60.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бутрова С.А. Терапия ожирения: влияние Орлистата (Ксеникал) на кардиометаболические факторы риска // Ожирение и метаболизм. - 2008. - № 3. - С. 20-23.</mixed-citation><mixed-citation xml:lang="en">Бутрова С.А. Терапия ожирения: влияние Орлистата (Ксеникал) на кардиометаболические факторы риска // Ожирение и метаболизм. - 2008. - № 3. - С. 20-23.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мельниченко Г.А., Комшилова К.А., Берковская М.А. Опыт применения препарата Орсотен (орлистат) у больных ожирением // Ожирение и метаболизм. - 2010. - № 1. - С. 46-50.</mixed-citation><mixed-citation xml:lang="en">Мельниченко Г.А., Комшилова К.А., Берковская М.А. Опыт применения препарата Орсотен (орлистат) у больных ожирением // Ожирение и метаболизм. - 2010. - № 1. - С. 46-50.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мычка В.Б. Метаболический синдром // Consilium medicum. - 2002. - № 11.</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Мычка В.Б. Метаболический синдром // Consilium medicum. - 2002. - № 11.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Alberti K.G.M.M., Eckel R.H., Grundy S.M. et al. Harmonizing the Metabolic Syndrome: А Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. - 2009. - № 120 (16). - Р. 1640-1645.</mixed-citation><mixed-citation xml:lang="en">Alberti K.G.M.M., Eckel R.H., Grundy S.M. et al. Harmonizing the Metabolic Syndrome: А Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. - 2009. - № 120 (16). - Р. 1640-1645.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey // JAMA. - 2002. - № 287 (3). - Р. 356-359.</mixed-citation><mixed-citation xml:lang="en">Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey // JAMA. - 2002. - № 287 (3). - Р. 356-359.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuhara A., Matsuda M. et al. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin // Science. - 2005. - № 307. - Р. 426-430.</mixed-citation><mixed-citation xml:lang="en">Fukuhara A., Matsuda M. et al. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin // Science. - 2005. - № 307. - Р. 426-430.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Graham T.E., Qin Yang et al. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese and Diabetic Subjects // NEJM. - 2006. - № 354. - Р. 2552-2563.</mixed-citation><mixed-citation xml:lang="en">Graham T.E., Qin Yang et al. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese and Diabetic Subjects // NEJM. - 2006. - № 354. - Р. 2552-2563.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension // Arch. Intern. Med. - 1989. - № 149. - Р. 1514-1520.</mixed-citation><mixed-citation xml:lang="en">Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension // Arch. Intern. Med. - 1989. - № 149. - Р. 1514-1520.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and Metabolic Syndrome // Arterioscler. Thromb. Vasc. Biol. - 2004. - № 24. - Р. 29-33.</mixed-citation><mixed-citation xml:lang="en">Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and Metabolic Syndrome // Arterioscler. Thromb. Vasc. Biol. - 2004. - № 24. - Р. 29-33.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">McTernan C.L., McTernan P.G., Harte A.L. et al. Resistin, central obesity, and type 2 diabetes // Lancet. - 2002. - № 36. - Р. 46-47.</mixed-citation><mixed-citation xml:lang="en">McTernan C.L., McTernan P.G., Harte A.L. et al. Resistin, central obesity, and type 2 diabetes // Lancet. - 2002. - № 36. - Р. 46-47.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mertens I., Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system // Obes. Rev. - 2002. - № 3(2). - Р. 85-101.</mixed-citation><mixed-citation xml:lang="en">Mertens I., Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system // Obes. Rev. - 2002. - № 3(2). - Р. 85-101.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Montague C.T., Prins J., Sanders B. et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution // Diabetes. - 1997. - № 46. - Р. 342-347.</mixed-citation><mixed-citation xml:lang="en">Montague C.T., Prins J., Sanders B. et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution // Diabetes. - 1997. - № 46. - Р. 342-347.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Reaven G.M. Banting lecture: role of insulin resistance in human disease // Diabetes. - 1988. - № 37. - Р. 1595-1607.</mixed-citation><mixed-citation xml:lang="en">Reaven G.M. Banting lecture: role of insulin resistance in human disease // Diabetes. - 1988. - № 37. - Р. 1595-1607.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C. Long term pharmacotherapy for obesity and overweight: updated meta-analysis // BMJ. - 2007. - № 335. - Р. 1194-1199.</mixed-citation><mixed-citation xml:lang="en">Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C. Long term pharmacotherapy for obesity and overweight: updated meta-analysis // BMJ. - 2007. - № 335. - Р. 1194-1199.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Steppan C.M., Bailey S.T., Bhat S. et al. The hormone resistin links obesity to diabetes // Nature. - 2001. - № 409. - Р. 307-312.</mixed-citation><mixed-citation xml:lang="en">Steppan C.M., Bailey S.T., Bhat S. et al. The hormone resistin links obesity to diabetes // Nature. - 2001. - № 409. - Р. 307-312.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
